食管癌为中国常见恶性肿瘤,其发病及病死率位居前列。对于临床1~3期食管癌,根据肿瘤位置及术者习惯采取Ivor Lewis或Ivor Lewis-Mckeown手术,是目前较为合理的治疗策略,符合以鳞癌为主的食管肿瘤流行病学特征,同时其具备纵隔淋巴结清扫优势,为胸外科医师所熟悉。食管癌整体5年生存率已达到了40.0%左右。胸外科医师不断追求,以实现更广范围淋巴结清扫、彻底的En Bloc切除,也使得围手期并发 Esophageal cancer is a common malignant tumor in China, and its incidence and mortality rank the forefront. For clinical stage 1 to stage 3 esophageal cancer, Ivor Lewis or Ivor Lewis-Mckeown surgery is the most reasonable treatment strategy according to the location of the tumor and the habit of the surgeon. It is in line with the epidemiological characteristics of esophageal cancer based on squamous cell carcinoma, With mediastinal lymph node dissection advantages, familiar to the surgeon. The overall 5-year survival rate of esophageal cancer has reached 40.0%. Continuous pursuit of thoracic surgeons to achieve a wider range of lymphadenectomy, complete En Bloc resection, but also makes the peri-occlusion period